Global Hot Flashes Treatment Market – Industry Trends and Forecast to 2030

Hot Flashes Treatment Market Analysis and Size

The global hot flashes treatment market is expected to witness significant growth during the forecast period. The increasing population of women is itself revealed as the most significant opportunity for the growth of host flashes treatment. As hot flashes is considered as the most common occurring symptom in menopause stage. About 65% of women complain of hot flashes for more than two years and 36% cry for more than five years.

Data Bridge Market Research analyses a growth rate in the global hot flashes treatment market in the forecast period 2023-2030. The expected CAGR of global hot flashes treatment market tend to be around 7% in the mentioned forecast period. The market was valued at USD 12.2 billion in 2022, and it would grow upto USD 20.96 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Hot Flashes Treatment Market Scope and Segmentation

Market Definition

Hot flashes are typically characterized by sudden mild or intense body heat because of the changes occurrence by hormones. This occurs due to decreased level of estrogens. The phenomenon of host flashes in men, young women, or pregnant ladies is projected because of medical conditions that may also disrupt the body’s ability to regulate temperature. It is mostly seen in menopause conditions. The hot flashes are generally belief to be lasting for 30 minutes. The common symptoms associated with hot flashes include feeling of anxiety, rapid heartbeat, perspiration on upper body, red and blotchy skin and palpitations.

Global Hot Flashes Treatment Market Dynamics

Drivers

• Increasing Prevalence of Hot Flashes Symptoms

As per the study "Hot Flashes" updated in December 2021 published in the National Center for Biotechnology Information (NCBI), hot flashes were among the most common types of menopausal vasomotor (VMS) symptoms, which is affecting up to 74% of perimenopausal women. Around 65% of women complain of hot flashes for more than two years and 36% cry for more than five years. Thus, this acts as a major factor boosting the market growth.

• Launch of Numerous Drugs Associated with Hot flashes

There has been several drug launches helping in treating this condition that are boosting the market growth. For instance, Novartis AG provides "Vivelle-DOT (estradiol transdermal system)" used to treat moderate and severe vasomotor symptoms because of menopause and to treat moderate to severe symptoms of vulvar and vaginal atrophy. In addition to this, the company Novo Nordisk Corporation launched a "Vagifem" 10 mcg tablet for vagin that treats changes in and around the vagina that generally occur after menopause and treats a combination of vaginal symptoms. Thus, it boosts the market growth.

Opportunities

• Increased Clinical Studies and Government Initiatives

The growing focus on research and development of treatment of hot flashes is pushing the growth of the market. For instance, in December 2021, Acer Therapeutics Inc. received U.S. FDA clearance of its Investigational New Drug (IND) application for its selective non-peptide neurokinin 3 receptors (NK3R) antagonist, ACER-801 (osanetant), for the potential treatment of induced Vasomotor Symptoms (iVMS).

• Increasing Awareness of Hot Flashes

The stakeholders in the hot flashes treatment market are working diligently towards spreading the awareness regarding the menopause, and trying to address the stigma associated with it, by launching numerous social media campaigns about the health issues related to menopause. The main aim is to literate the female population, also helping the players promote alternative solutions for managing hot flashes.

 Restraints/Challenges

• Risk of Complications

There are high risk of complications associated with the hot flashes treatment. Complications such as headache, upset stomach, vomiting, stomach cramps, appetite and weight changes and many others are witnessed post the therapy. Thus, it hampers the market growth.

• High Cost

The huge expenditure associated with these therapies hamper the market growth. The hormonal treatment definitely involves a heavy cost and thus hampers the market growth.

This global hot flashes treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hot flashes treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Hot Flashes Treatment Market  

The COVID-19 epidemic has affected the supply chain of several pharmaceutical products. The restrictions associated with the production and export of medicines have largely affected many imported products, such as the U.S., Europe, and other countries. During this period, several pharmaceutical companies manufacture some of the medicines indoors, and some of the company's medicines are manufactured with foreign materials, such as contract production services, which also contributed to the supply of products. As per a study titled "Inactive Lifestyles Lead to More Frequent, Severe Hot Flashes: Study" published in September 2021, in the age of COVID-19, sedentary behavior, working from home, traveling less has increased the incidence of hot flashes and menopause in women, which has majorly impacted the market.

Global Hot Flashes Treatment Market Scope

The global hot flashes treatment market is segmented on the basis of type, route of administrtaion, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Hormonal Treatment
• Estrogen
• Progesterone
• Estrogen-Progesterone Combination
• Non-Hormonal Treatment
• Antidepressant
• Other Non-hormonal Treatments

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Hot Flashes Treatment Market Regional Analysis/Insights

The global hot flashes treatment market is analyzed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global hot flashes treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global hot flashes treatment market throughout the forecast period due to increased new research and developments on hot flashes treatment market.

Asia-Pacific dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Hot Flashes Treatment Market Share Analysis

The global hot flashes treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hot flashes treatment market

Key players operating in the global hot flashes treatment market include:

• AbbVie Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Cipla Inc. (India)
• Lupin (India)
• Sun Pharmaceuticals Industries Ltd. (India
• Hikma Pharmaceuticals PLC (U.K.)
• Boehringer Ingelheim International GmbH (Germany)
• Sanofi (France)
• AstraZeneca (U.K.)
• GSK Plc. (U.K.)
• Pfizer Inc. (U.S.)
• Novartis AG (Switzerland)
• Mylan N.V (U.S.)
• Hisamitsu Pharmaceutical Co.,Inc (Japan)
• Merck & Co., Inc. (U.S.)
• TherapeuticsMD, Inc (U.S.)
• Lilly (U.S.)
• Emcure Pharmaceuticals Limited (India)
• Bayer AG (Germany)

Research Methodology: Global Hot Flashes Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

SKU-55993